The expansion project is expected to increase the site’s footprint by 32,000ft² to add capacity for the handling and storage of clinical trial supply materials at controlled room temperatures
Catalent begins expansion project at its clinical supply facility in Schorndorf, Germany. (Credit: Darko Stojanovic from Pixabay)
Catalent, a drug delivery technologies and development solutions provider, has started construction on a $20m expansion project at its clinical supply facility in Schorndorf, Germany.
The project is expected to increase the site’s footprint by 32,000ft² to add capacity for the handling and storage of clinical trial supply materials at controlled room temperatures between 15-25 degrees Celsius.
Expected to be completed by June 2024, the project will create space in the original plant to adjust the commissioning of a new, fully automatic bottle-filling line, and a special area for the firm’s FastChain demand-led supply service.
Catalent clinical development and supply division head and president Ricky Hopson said: “Our site in Schorndorf plays a key strategic role in our global clinical supply network, and this expansion will provide much-needed capacity and capabilities to meet the growing needs of customers.
“Additional temperature-controlled handling, storage, and distribution means the facility is well-equipped to respond to the growing demand for clinical supply capacity and services in the region, including for products requiring cold chain support.
“Working closely with our adjacent oral dose manufacturing centre of excellence, and our European development centres for oral, biologic, cell therapy and gene therapy products, customers have access to fully integrated development, clinical packaging, and distribution solutions.”
The Schorndorf clinical supply facility was opened in 1996 to offer clinical supply services like primary and secondary packaging, multi-lingual project services, labelling, clinical storage and distribution, and returns and destruction.
Catalent’s FastChain demand-led supply service is said to be a continuous Good Manufacturing Practice (GMP) approach.
It disintegrates primary from secondary packaging to generate cost-effective and timely adaptation and regional supply of clinical materials.
In February this year, Catalent finished the previously announced $2.2m expansion project of its clinical supply facility in Singapore. The project has resulted in a 20% increase in the floor space of the facility.